Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Glucagon receptor | ||
Ligand | BDBM50244265 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_491826 (CHEMBL945216) | ||
IC50 | 1±n/a nM | ||
Citation | Kim, RM; Chang, J; Lins, AR; Brady, E; Candelore, MR; Dallas-Yang, Q; Ding, V; Dragovic, J; Iliff, S; Jiang, G; Mock, S; Qureshi, S; Saperstein, R; Szalkowski, D; Tamvakopoulos, C; Tota, L; Wright, M; Yang, X; Tata, JR; Chapman, K; Zhang, BB; Parmee, ER Discovery of potent, orally active benzimidazole glucagon receptor antagonists. Bioorg Med Chem Lett18:3701-5 (2008) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Glucagon receptor | |||
Name: | Glucagon receptor | ||
Synonyms: | GCGR | GL-R | GLR_HUMAN | Glucagon Receptor (GCGR) | Glucagon receptor (GlucR) | ||
Type: | Enzyme | ||
Mol. Mass.: | 54026.92 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P47871 | ||
Residue: | 477 | ||
Sequence: |
| ||
BDBM50244265 | |||
n/a | |||
Name | BDBM50244265 | ||
Synonyms: | CHEMBL480113 | trans-4-((4-tert-butylcyclohexyl)(1-methyl-6-propoxy-1H-benzo[d]imidazol-2-yl)amino)methyl)-N-(1H-tetrazol-5-yl)benzamide | ||
Type | Small organic molecule | ||
Emp. Form. | C30H40N8O2 | ||
Mol. Mass. | 544.691 | ||
SMILES | CCCOc1ccc2nc(N(Cc3ccc(cc3)C(=O)Nc3nnn[nH]3)[C@H]3CC[C@@H](CC3)C(C)(C)C)n(C)c2c1 |r,wU:26.27,wD:29.34,(9.13,-42.84,;9.87,-44.19,;11.41,-44.22,;12.15,-45.57,;13.69,-45.6,;14.49,-44.28,;16.03,-44.32,;16.76,-45.67,;18.26,-46.03,;18.38,-47.56,;19.71,-48.34,;19.71,-49.88,;21.04,-50.66,;22.37,-49.89,;23.7,-50.67,;23.69,-52.21,;22.34,-52.97,;21.02,-52.19,;25.02,-52.99,;25.01,-54.53,;26.36,-52.22,;27.68,-53,;28.2,-54.45,;29.74,-54.42,;30.18,-52.94,;28.91,-52.06,;21.04,-47.58,;21.05,-46.04,;22.39,-45.28,;23.72,-46.06,;23.71,-47.6,;22.37,-48.36,;25.06,-45.3,;26.39,-44.52,;25.83,-46.64,;24.3,-43.97,;16.96,-48.15,;16.19,-49.49,;15.96,-46.98,;14.43,-46.95,)| | ||
Structure |